Commentary

Latest

News

Latest

ICS-Based Treatments Take Center Stage in GINA 2024 Guidelines

The 2024 GINA updates shift asthma management from reactive to proactive, taking a more holistic approach that is consistent with other chronic diseases, aiming to improve long-term outcomes. ICS-containing inhalers are now recommended for both reliever and maintenance therapy, emphasizing the need for simplifying treatment regimens.

Resource Page

Latest

Polls

Case: 76-yr old male s/p CABG 10 yr ago; hx of CAD, STEMI, PAD and Afib. Currently taking ASA 81mg and Clopidogrel 75mg daily. What's the best approach to prevent CVD events?

  • Continue ASA and Clopidogrel (6%, 13 Votes)
  • Continue ASA; d/c Clopidogrel (20%, 42 Votes)
  • Continue ASA and Clopidogrel; add DOAC (8%, 16 Votes)
  • Continue Clopidogrel; add DOAC; d/c ASA (39%, 80 Votes)
  • Stop ASA and Clopidogrel; start DOAC (27%, 55 Votes)

Total Voters: 206

Loading ... Loading ...

About

iForumRx.org is a web-based community of practice designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence.